2C-T-7: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Research Materials -> Research chemicals |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid)"> | |||
Erowid's dosage documentation for oral 2C-T-7<ref name="erowid-2ct7-dose"> | |||
Erowid. 2C-T-7 Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/2ct7/2ct7_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers: | |||
* '''Threshold:''' 3-5 mg | |||
* '''Light:''' 10-20 mg | |||
* '''Common:''' 15-30 mg | |||
* '''Strong:''' 10-50 mg | |||
* '''Heavy:''' 25-60 mg | |||
Onset 20 to 140 minutes depending on preparation form and stomach | |||
contents; duration 6 to 12 hours. | |||
</titration> | |||
<titration slug="erowid-dose-insufflated" author="erowid-claude" | |||
title="Insufflated dose ladder (Erowid) -- SAFETY WARNING"> | |||
Insufflated tiers reported by Erowid (CAUTION: multiple fatalities | |||
documented):<ref name="erowid-2ct7-dose"/> | |||
* '''Threshold:''' 1-3 mg | |||
* '''Light:''' 2-10 mg | |||
* '''Common:''' 5-15 mg | |||
* '''Strong:''' 5-20 mg | |||
* '''Heavy:''' 7-25+ mg | |||
Onset 5 to 60 minutes; duration 2 to 5 hours. Erowid documents fatal | |||
incidents associated with insufflated doses in the 30-35 mg range. | |||
Erowid's guidance: "dosages this small must be measured very very | |||
carefully." The safety margin for insufflated 2C-T-7 is narrow. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||